Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Feb 19;308(6927):506–509. doi: 10.1136/bmj.308.6927.506

Use of antidepressants among people committing suicide in Sweden.

G Isacsson 1, P Holmgren 1, D Wasserman 1, U Bergman 1
PMCID: PMC2542784  PMID: 8136668

Abstract

OBJECTIVE--To analyse the outcome of depression in the Swedish population as reflected by the detection of antidepressants in a national forensic toxicological screening programme of unnatural deaths. DESIGN--Antidepressants detected by the National Laboratory of Forensic Chemistry were related to data on use expressed in person years of exposure. SUBJECTS--All 7000 cases of unnatural death with results from forensic toxicological screening in 1990-1; this included 3400 (85%) of the 4000 cases of suicide in Sweden. MAIN OUTCOME MEASURES--Number of findings of antidepressants in the screening programme and number of findings of different antidepressants in relation to their use. RESULTS--Antidepressants were found in 585 screening tests, corresponding to 542 subjects or less than 16% of the 3400 cases of suicide. Newer, less toxic antidepressants were found more often than the older compounds. Toxic concentrations of antidepressants were found in only 190 cases (5.6%). CONCLUSION--A consistent finding in surveys of suicide is that about half of the patients who commit suicide are depressed. The current data suggest that most depressed patients who commit suicide are not taking antidepressants immediately before death. Therapeutic failure may be a greater problem with antidepressants than toxicity as the results did not indicate any advantage of the newer, less toxic antidepressants. All causes of death should be included in risk analyses, thereby providing an estimate of effectiveness as well as toxicity of antidepressants.

Full text

PDF
507

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barraclough B., Bunch J., Nelson B., Sainsbury P. A hundred cases of suicide: clinical aspects. Br J Psychiatry. 1974 Oct;125(0):355–373. doi: 10.1192/bjp.125.4.355. [DOI] [PubMed] [Google Scholar]
  2. Bergman U. Pharmacoepidemiological perspectives. J Clin Epidemiol. 1992 Mar;45(3):313–317. doi: 10.1016/0895-4356(92)90092-2. [DOI] [PubMed] [Google Scholar]
  3. Cassidy S., Henry J. Fatal toxicity of antidepressant drugs in overdose. Br Med J (Clin Res Ed) 1987 Oct 24;295(6605):1021–1024. doi: 10.1136/bmj.295.6605.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Derby L. E., Jick H., Dean A. D. Antidepressant drugs and suicide. J Clin Psychopharmacol. 1992 Aug;12(4):235–240. [PubMed] [Google Scholar]
  5. Forster D. P., Frost C. E. Medicinal self-poisoning and prescription frequency. Acta Psychiatr Scand. 1985 Jun;71(6):567–574. doi: 10.1111/j.1600-0447.1985.tb02550.x. [DOI] [PubMed] [Google Scholar]
  6. Guess H. A., Lydick E. G., Small R. D., Miller L. P. Epidemiologic programs for computers and calculators. Exact binomial confidence intervals for the relative risk in follow-up studies with sparsely stratified incidence density data. Am J Epidemiol. 1987 Feb;125(2):340–347. doi: 10.1093/oxfordjournals.aje.a114535. [DOI] [PubMed] [Google Scholar]
  7. Hanzlick R. Postmortem tricyclic antidepressant concentrations. Lethal versus nonlethal levels. Am J Forensic Med Pathol. 1989 Dec;10(4):326–329. doi: 10.1097/00000433-198912000-00009. [DOI] [PubMed] [Google Scholar]
  8. Isacsson G., Boëthius G., Bergman U. Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden. Acta Psychiatr Scand. 1992 Jun;85(6):444–448. doi: 10.1111/j.1600-0447.1992.tb03209.x. [DOI] [PubMed] [Google Scholar]
  9. Kelleher M. J., Daly M., Kelleher M. J. The influence of antidepressants in overdose on the increased suicide rate in Ireland between 1971 and 1988. Br J Psychiatry. 1992 Nov;161:625–628. doi: 10.1192/bjp.161.5.625. [DOI] [PubMed] [Google Scholar]
  10. Montgomery S. A., Lambert M. T., Lynch S. P. The risk of suicide with antidepressants. Int Clin Psychopharmacol. 1988 Nov;3 (Suppl 2):15–24. [PubMed] [Google Scholar]
  11. Regier D. A., Hirschfeld R. M., Goodwin F. K., Burke J. D., Jr, Lazar J. B., Judd L. L. The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis. Am J Psychiatry. 1988 Nov;145(11):1351–1357. doi: 10.1176/ajp.145.11.1351. [DOI] [PubMed] [Google Scholar]
  12. Rorsman B., Hagnell O., Lanke J. Violent death and mental disorders in the Lundby Study. Accidents and suicides in a total population during a 25-year period. Neuropsychobiology. 1982;8(5):233–240. doi: 10.1159/000117904. [DOI] [PubMed] [Google Scholar]
  13. Wessling A., Bergman U., Westerholm B. On the differences in psychotropic drug use between the three major urban areas in Sweden. Eur J Clin Pharmacol. 1991;40(5):495–500. doi: 10.1007/BF00315229. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES